Literature DB >> 22771284

Anxiety and motor fluctuations in Parkinson's disease: a cross-sectional observational study.

A F G Leentjens1, K Dujardin, L Marsh, P Martinez-Martin, I H Richard, S E Starkstein.   

Abstract

BACKGROUND: Some studies have suggested a relationship between anxiety and motor fluctuations in patients with Parkinson's disease (PD). AIM: To describe the nature of the relationship between anxiety symptoms and motor fluctuations and to describe the anxiety symptoms encountered during 'off', 'on' and 'on with dyskinesia' phases. DESIGN AND METHODS: In this cross-sectional study, 250 patients with idiopathic PD, of whom 118 had motor fluctuations, underwent a standardized clinical assessment including the Unified Parkinson's Disease Rating Scale (UPDRS), the DSM IV criteria for major depression and anxiety disorders, the Hamilton Depression Rating Scale (HAMD), and the Hamilton Anxiety Rating Scale (HARS). In addition, patients with motor fluctuations were administered a questionnaire to assess the presence of anxiety symptoms and their relation to motor states.
RESULTS: Patients with motor fluctuations suffer from generalized anxiety disorder more often than patients without motor fluctuations. When patients with motor fluctuations have anxiety symptoms, the majority report that these have no temporal relationship with specific motor states. When there was a relationship, symptoms were almost always related to 'off' periods. However, a minority of patients experience anxiety symptoms during 'on' or "on with dyskinesia" periods exclusively.
CONCLUSION: Our findings suggest that the relationship between anxiety and motor fluctuations is more complex than can be explained solely by 'wearing off' phenomena of levodopa. Further studies investigating the temporal dynamics of anxiety and motor fluctuations are needed.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22771284     DOI: 10.1016/j.parkreldis.2012.06.007

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  23 in total

1.  Associations of specific psychiatric disorders with isolated focal dystonia, and monogenic and idiopathic Parkinson's disease.

Authors:  Susanne Steinlechner; Johann Hagenah; Hans-Jürgen Rumpf; Christian Meyer; Ulrich John; Tobias Bäumer; Norbert Brüggemann; Meike Kasten; Alexander Münchau; Christine Klein; Rebekka Lencer
Journal:  J Neurol       Date:  2017-04-11       Impact factor: 4.849

2.  Neuropsychiatric characteristics of GBA-associated Parkinson disease.

Authors:  Matthew Swan; Nancy Doan; Robert A Ortega; Matthew Barrett; William Nichols; Laurie Ozelius; Jeannie Soto-Valencia; Sarah Boschung; Andres Deik; Harini Sarva; Jose Cabassa; Brooke Johannes; Deborah Raymond; Karen Marder; Nir Giladi; Joan Miravite; William Severt; Rivka Sachdev; Vicki Shanker; Susan Bressman; Rachel Saunders-Pullman
Journal:  J Neurol Sci       Date:  2016-08-30       Impact factor: 3.181

Review 3.  Systematic review of factors associated with depression and anxiety disorders among older adults with Parkinson's disease.

Authors:  Atami Sagna; Joseph J Gallo; Gregory M Pontone
Journal:  Parkinsonism Relat Disord       Date:  2014-04-01       Impact factor: 4.891

Review 4.  Psychiatric issues in cognitive impairment.

Authors:  Dag Aarsland; John-Paul Taylor; Daniel Weintraub
Journal:  Mov Disord       Date:  2014-04-15       Impact factor: 10.338

5.  Neuropsychiatric Complications of Parkinson Disease Treatments: Importance of Multidisciplinary Care.

Authors:  Jacob Taylor; William S Anderson; Jason Brandt; Zoltan Mari; Gregory M Pontone
Journal:  Am J Geriatr Psychiatry       Date:  2016-09-03       Impact factor: 4.105

6.  Affective Correlates of Psychosis in Parkinson's Disease.

Authors:  Stewart A Factor; Michael K Scullin; Alan Freeman; Donald L Bliwise; William M McDonald; Felicia C Goldstein
Journal:  Mov Disord Clin Pract       Date:  2016-06-16

7.  The impact of motor symptoms on self-reported anxiety in Parkinson's disease.

Authors:  Robert D Salazar; Asher M Le; Sandy Neargarder; Alice Cronin-Golomb
Journal:  Parkinsonism Relat Disord       Date:  2017-01-24       Impact factor: 4.891

8.  Nigrostriatal dopamine transporter availability, and its metabolic and clinical correlates in Parkinson's disease patients with impulse control disorders.

Authors:  I Navalpotro-Gomez; R Dacosta-Aguayo; F Molinet-Dronda; A Martin-Bastida; A Botas-Peñin; H Jimenez-Urbieta; M Delgado-Alvarado; B Gago; A Quiroga-Varela; Maria C Rodriguez-Oroz
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-07-04       Impact factor: 9.236

Review 9.  Depression and Parkinson's disease: current knowledge.

Authors:  Laura Marsh
Journal:  Curr Neurol Neurosci Rep       Date:  2013-12       Impact factor: 5.081

10.  Pharmacologic treatment of anxiety disorders in Parkinson disease.

Authors:  Gregory M Pontone; James R Williams; Karen E Anderson; Gary Chase; Susanne R Goldstein; Stephen Grill; Elaina S Hirsch; Susan Lehmann; John T Little; Russell L Margolis; Justin Palanci; Peter V Rabins; Howard D Weiss; Laura Marsh
Journal:  Am J Geriatr Psychiatry       Date:  2013-03-29       Impact factor: 4.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.